MH_I_L: Mental Health Sciences I. Lectures
Mr. Baksa, Dániel
Department of Pharmacodynamics, Semmelweis University
205272302
baksadan@gmail.com
A Genetic Study of Migraine and Comorbid Depression
Daniel Baksa1,2, Peter Petschner1,3,4, Gabor Hullam4,5, Dora Torok1, Andras Millinghoffer4,5,6, Gyorgy Bagdy1,4,6, Gabriella Juhasz1,2,4
1 Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary
2 SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary
3 Bioinformatics Center, Institute for Chemical Research, Kyoto University, Gokasho, Uji, Kyoto, Japan
4 MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary
5 Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
6 NAP-2-SE New Antidepressant Target Research Group, Semmelweis University, Budapest, Hungary
Szóbeli
Mental Health Sciences I. Lectures
Hungarian
Mental Sciences
No consent for the publication for this abstract.
Semmelweis University, Doctoral School of Mental Health Sciences
Gabriella Juhász
I do not give consent to the publication of my abstract on the website of the congress.
Szabad
elfogadva
szóbeli
nem rendelkezett róla
4105
09:30
09:45
Daniel Baksa1,2, Peter Petschner1,3,4, Gabor Hullam4,5, Dora Torok1, Andras Millinghoffer4,5,6, Gyorgy Bagdy1,4,6, Gabriella Juhasz1,2,4
1 Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary
2 SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary
3 Bioinformatics Center, Institute for Chemical Research, Kyoto University, Gokasho, Uji, Kyoto, Japan
4 MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary
5 Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
6 NAP-2-SE New Antidepressant Target Research Group, Semmelweis University, Budapest, Hungary